These data suggest that macrophage necroptosis mediated by GDCA/S1PR2/ZBP1/p-MLKL plays a significant role in the pathogenesis of cholestasis-induced liver fibrosis, and may represent a potential therapeutic strategy for BA. This evidence concerns the gene ZBP1 and Hepatic fibrosis.